Home India Ministry of Health and Family Welfare Update on National HPV Vaccination Programme...
Date: 2026-03-17 Category: Press Release State: Union Government Country: India

Update on National HPV Vaccination Programme

Issued by Ministry of Health and Family Welfare · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

**Executive Summary** The Government of India launched a nationwide free HPV vaccination campaign on 28th February 2026 to reduce the burden of cervical cancer. The program targets approximately 1.2 crore girls aged 14 years across all 36 States and Union Territories using the single-dose Gardasil-4 vaccine. Following an initial three-month campaign, the vaccine will transition to the routine immunization schedule at government health facilities. **Key Points / Main Content** **Campaign Overview and Logistics** * **Launch Date:** The nationwide campaign commenced on 28th February 2026. * **Target Demographic:** Approximately 1.2 crore eligible girls aged 14 years. * **Geographic Reach:** Implementation covers all 36 States and Union Territories, including rural and underserved areas. * **Duration:** An intensive campaign will run for three months, after which the vaccine will remain available during routine immunization days. **Vaccine Administration** * **Vaccine Type:** Single-dose Gardasil-4. * **Cost:** Administered free of cost at government health facilities, including Primary Health Centres (PHCs), Community Health Centres (CHCs), District Hospitals, and Government Medical Colleges. * **Clinical Oversight:** Vaccines are administered in the presence of medical officers. **Safety and Consent Protocols** * **Consent Requirement:** Vaccination is voluntary, but parental consent is mandatory for administration. * **Adverse Event Management:** All vaccination sites are linked to 24x7 Adverse Events Following Immunization (AEFI) Management Centers for prompt treatment of any side effects. * **Transparency:** Efficacy details are available via the Summary of Product Characteristics (SmPC) on the CDSCO website. **Strategic Framework** * **Comprehensive Strategy:** The program is part of a multi-faceted approach including screening, early diagnosis, and timely treatment. * **Operational Guidelines:** Formal guidelines for the rollout have been disseminated to all States and Union Territories. **Impact Analysis** **Eligible Beneficiary Girls (Aged 14)** * **Impact:** They receive free, preventative medical intervention against cervical cancer. * **Action Required:** Visit designated government health facilities to receive the single-dose vaccine. **Parents and Guardians** * **Impact:** They serve as the primary decision-makers for the child’s participation in the program. * **Action Required:** Provide mandatory formal consent before the vaccine can be administered to their children. **State and Union Territory Governments** * **Impact:** They are responsible for the localized execution and management of the nationwide campaign. * **Action Required:** Implement the program according to the operational guidelines disseminated by the central government. **Government Health Facilities and Medical Officers** * **Impact:** These entities are the primary service providers and safety monitors for the campaign. * **Action Required:** Ensure the presence of medical officers during administration and maintain 24x7 links to AEFI Management Centers.

Key Entities Referenced

National HPV Vaccination Programme: A nationwide campaign launched in 2026 to provide free single-dose HPV vaccinations to approximately 1.2 crore girls aged 14 years across India. Gardasil-4 vaccine: The specific single-dose vaccine administered free of cost at government health facilities as part of the country's cervical cancer prevention strategy. Ayushman Arogya Mandirs: Government health facilities, including Primary Health Centres, serving as the primary delivery points for the administration of the HPV vaccine. Ministry of Health and Family Welfare: The central ministry responsible for implementing the multi-faceted approach of screening, diagnosis, and vaccination to reduce the burden of cervical cancer. Central Drugs Standard Control Organisation (CDSCO): The national regulatory body whose website provides the Summary of Product Characteristics (SmPC) and efficacy details for approved HPV vaccines.
Official Source Record View Original Source →
See Full Document Text
Ministry of Health and Family Welfare Update on National HPV Vaccination Programme Single-dose Gardasil-4 vaccine is administered free of cost at government health facilities across all areas including rural and underserved area Government of India has implemented a multi-faceted approach that includes screening, early diagnosis and timely treatment, aiming to reduce the burden of this disease among women in the country Posted On: 17 MAR 2026 1:15PM by PIB Delhi The Nationwide free HPV vaccination campaign was launched on 28th February 2026, targeting approximately 1.2 crore eligible beneficiary girls aged 14 years across all 36 States and Union Territories. The single-dose Gardasil-4 vaccine is administered free of cost at government health facilities, including Ayushman Arogya Mandirs- Primary Health Centres (PHCs), Community Health Centres (CHCs), Sub- District Hospitals (SDH)/District Hospitals (DHs) & Government Medical Colleges (GMCs) across all areas including rural and underserved area. After the campaign duration of three-months, the vaccine will continue to be available on routine immunization days. The vaccines are being administered in the presence of medical officers and the vaccination sites are linked to 24x7 Adverse Events Following Immunization (AEFI) Management Centers for prompt management of adverse events, if any. HPV vaccination is voluntary and parental consent is mandatory before administration of vaccine. The operational guidelines for the roll out of HPV vaccination campaign have been disseminated to all States/UTs. The Government of India has implemented comprehensive prevention strategies against cervical cancer, encompassing a multi-faceted approach that includes screening, early diagnosis, and timely treatment, aiming to reduce the burden of this disease among women in the country. Complementing these initiatives, HPV vaccination, based on global evidence, has been envisaged to play a significant role in reducing cervical cancer incidence in India. Details of efficacy of approved HPV vaccines are published in Summary of Product Characteristics (SmPC) which are publicly available on CDSCO website. The Union Minister of State for Health and Family Welfare, Smt. Anupriya Patel stated this in a written reply in the Rajya Sabha today. ***** SRHFW/PQ-Update on HPV Vaccination Programme/17 March 2026/3 (Release ID: 2241079) Visitor Counter : 273 Read this release in: Urdu , ही , Bengali , Gujarati , Telugu

Continue your research